Spherical Crystallization for Lean Solid-Dose Manufacturing (Part 1) - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Spherical Crystallization for Lean Solid-Dose Manufacturing (Part 1)
In Part I of this article, the authors describe the materials and methods used in developing a screening strategy to accelerate the preparation and characterization of spherical agglomerates by spherical crystallization.


Pharmaceutical Technology
Volume 34, Issue 3, pp. 72-75

References

1. P. McKenzie et al., AIChE J. 52 (12), 3990–3994 (2006).

2. N.A. Lewis, Pharm. Technol. 30 (10), 94–108 (2006).

3. T. Lee and F.B. Hsu, Drug Dev. Ind. Pharm. 33 (11), 1273–1284 (2007).

4. T. Lee et al., Drug Dev. Ind. Pharm. 34 (5), 522–535 (2008).

5. Y. Kawashima and C.E. Capes, Powder Technol. 10 (1), 85–92 (1974).

6. Y. Kawashima and C.E. Capes, Powder Technol. 13 (2), 279–288 (1976).

7. Y. Kawashima, M. Okumura, and H. Takenaka, Science 216 (4550), 1127–1128 (1982).

8. Y. Kawashima et al., J. Pharm. Sci. 73 (10) 1407–1409 (1984).

9. Y. Kawashima, M. Okumura, and H. Takenaka, Powder Technol. 39 (1), 41–47 (1984).

10. Y. Kawashima et al., J. Pharm. Sci. 74 (11), 1152–1156 (1985).

11. A. Sano, Chem Pharm. Bull. 37 (8), 2183–2187 (1989).

12. Y. Kawashima et al., J. Pharm. Sci. 80 (5), 472–478 (1991).

13. K. Morishima et al., Powder Technol. 76 (1), 57–64 (1993).

14. Y. Kawashima et al., Powder Technol. 78 (2), 151–157 (1994).

15. K. Morishima et al., Int. J. Pharm. 105 (11), 11–18 (1994).

16. A.M. Garcia and E.S. Ghaly, J. Controlled Release 40 (3), 179–186 (1996).

17. A.H.L. Chow and M.W.M. Leung, Drug Dev. Ind. Pharm. 22 (4), 357–371 (1996).

18. U. Teipel, T. Heintz, and H.H. Krause, Propellants, Explosives, Pyrotechnics 25 (2), 81–85 (2000).

19. P. Szabó-Révész et al., Powder Technol. 114 (1), 118–124 (2001).

20. A.R. Paradkar et al., Drug Dev. Ind. Pharm. 28 (10), 1213–1220 (2002).

21. P. Szabó-Révész et al., J. Crystal Growth 237–239 (Part 3), 2240–2245 (2002).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here